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Abstract
Background: Uterine fibroids are the most common benign tumor in female reproductive system and a major cause in declining their quality of live. Patient characteristics has high prevalence in black women, 40s, nulliparous, and early menarche. These characteristics are varied in some areas and considered in 
treatment decisions. The objectives of this study was to describe the uterine fibroid patient characteristics at Dr. Hasan Sadikin General Hospital, Bandung from 1 January 2013 to 31 December 2015.
Methods: A descriptive study was conducted to 255 medical records of patients with uterine fibroids at Dr. Hasan Sadikin General Hosiptal, Bandung from 1 January 2013 to 31 December 2015. This study was conducted from September to November 2016. The variables were the year of treatment, age, education, 
occupation, married status, menarche, abortion, parity, type of uterine fibroids, and treatment. The collected data were analyzed and presented using frequency tables and percentages.
Results: Most cases of uterine fibroids were discovered in 2014. The most characteristics with uterine 
fibroids were pre-menopausal age (41.18%), high school education (55.69%), housewife (63.14%), normal 
menarche (54.51%), married (92.16%), nulliparous (47.45%), no abortion (76.47%), multiple uterine 
fibroids (46.67%), and hysterectomy (58.04%).
Conclusions: The most combination of characteristics of patients with uterine fibroids is nulliparrous 
women in reproductive and pre-menopausal age with normal menarche. 
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Introduction
Uterine fibroids are benign tumors from smooth muscle of the uterus and most commonly occur in the female reproductive system, especially in the forties.1,2,3 In the United States3, 60% of 35 years old African-
American women have uterine fibroids. In Brazil4, uterine fibroids occur most commonly 
in the 35-44 years, and among white race l. In Ghanaian women, this condition occurred  <35 years old and the type was intramural uterine 
fibroids.5 In Indonesia6, this condition ranks second of all gynecological cancer. A study in Medan7 in the period 2009–2011, uterine 
fibroids had high prevalence in the 40–49 years old, high school graduation, work as housewife, married, multiparous and the type 
was submucosal fibroids.There are several factors suspected to 
be the cause of uterine fibroids such as 
socio-demographic, hormones, genetics, and lifestyle factors.8 Menarche, parity, age, obesity, smoking, diet, and exercise are several predictors contributing to the development of 
uterine fibroids.9 These factors can be assessed 
by identification of the patient characteristics and can be a source of information to consider treatment options.1 Dr. Hasan Sadikin General Hospital Bandung which is the top referral hospital in West Java 
has not yet published data on uterine fibroids patient characteristics. Based on this, the study 
was conducted to identify the uterine fibroids patient characteristics at Dr. Hasan Sadikin General Hospital Bandung. 
MethodsA descriptive quantitative study was conducted involving medical records of 
uterine fibroid patients in the Department of 
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Obstetrics and Gynecology, Dr. Hasan Sadikin General Hospital from 1 January 2013 to 31 
December 2015 (3 years data). This study was conducted from September to November 2016 and approved by the Health Research Ethics Committee of the Faculty of Medicine of Universitas Padjadjaran, No 631/UN6.C1.3.2/KEPK/PN/2016 and Dr. Hasan Sadikin General Hospital Bandung, No. 4740 / UN6.C1 / PP / 2016.The inclusion criteria for the medical records were medical records consisting of information about the year of treatment, age, education, occupation, menarche, married 
status, parity, abortion, type of uterine fibroids, and treatment. While exclusion criteria were incomplete medical records according to the variables needed. There were 383 medical records during 3 years, however only 255 medical records met the inclusion criteria.In terms of age,  age was divided into four groups according to the women’s uterine development, namely, the reproductive 
age (15–40 years), pre-menopause (41–46 
years), menopause (47–51 years) and post-
menopause (≥52 years). The intervals of menarche were divided based on the age of the 
Table 1 Distribution Uterine Fibroids Patients characteristics in Dr. Hasan Sadikin General 
  Hospital Bandung from 2013–2015
Variable Classification N %Years of treatment 2013 68 26.672014 94 36.862015 93 36.47Age 15–40 years 95 37.25
41–46 years 105 41.18
4–51 years 44 17.25
≥ 52 years 11 43.1Education Elementary school 32 12.55Junior high school 28 10.98Senior high school 142 55.69College 53 20.78Occupation Housewife 161 63.14Entrepreneur 12 4.71Employee 42 16.47Government employee 25 9.80Other 15 5.88Married status Unmarried 20 7.84Married 235 92.16
first menstruation, namely, early menarche 
(<11 years), normal menarche (11–13 years), 
menarche tarda (14–16 years) and late 
menarche (≥17 years). Moreover, parity was divided into four groups based on the number 
of delivery, namely nulliparous (null birth), 
primiparous (first birth), multiparous (2–5 
births), and grandemultiparous (> 5 births). The collected data were analyzed using a computer software and were presented by frequency tables and percentages. 
Results
This study discovered that women aged 41–46 years had the highest percentage of uterine 
fibroids, followed by women aged 15–40 years. Most of the patients were high school 
graduates, housewives and married (Table 1).In terms of menarche, girls in the age group 
11–13 years had the highest percentage of this disease, followed by girls in the age group 
14–16 years. The highest percentage of the case was in the never abortus, nulliparous and multiple group. There were some options to 
treat uterine fibroids. This study discovered 
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that the most common treatment conducted 
to this condition was hysterectomy (Table 2).Based on the combination of variables age, menarche, and parity on the incidence 
of uterine fibroid and treatment options this study discovered that the most  cases of 
uterine fibroids in the reproductive age group 
had normal menarche (11–13 years) and 
nulliparous (Tables 3,4,5) .
In terms of the pre-menopause group, this study discovered a similar result as in the reproductive group. Most cases of uterine 
fibroids were patients who had normal 
menarche and nulliparous (Table 3).Compared to other groups, the cases of 
uterine fibroids in the menopause group had a slightly different result. Most cases were still in patients who had normal menarche age but 
had more than two children (Table 4).In this study there were small low cases 
of uterine fibroids in the post menopause age 
group. There were only 4.31% cases compared to other groups. Hence, most cases had 
menarche tarda and more than five children 
(Table 5).Furthermore, treatment options based on the number of parity was hysterectomy, while 
based on age was myomectomy. A combination characteristics on hysterectomy was the most 
widely experienced by pre-menopause (41–
46 years), menarche tarda (14–16 years) and 
multiparrous (2–5 births), while myomectomy was performed to women who were in the 
reproductive age (15–40 years), normal 
menarche (11–13 years), and nulliparous.
Discussions
Uterine fibroid is a benign tumor that causes the highest morbidity among women in reproductive age and fewer than in menopause. It consists of many smooth muscle cells and different types of connective tissue. Growth of the tumor presses to the multiple networks of myometrium and connective tissue, and 
causes the formation of pseudo-capsule that 
consists of lots of collagen fibers and blood vessels.10,11 Hormones, gen, and growth factors were factors suspected to contribute to the 
development of uterine fibroids.12This study discovered that most cases 
of uterine fibroids occurred in the pre-menopouse group. This result was in 
Table 2 Distribution of Uterine Fibroids Based on Obstetrics and Gynecology Status of 
  Patients in Dr. Hasan Sadikin General Hospital Bandung from 2013–2015.
Variable Categories n %Menarche < 11 years 10 3.92
11–13 years 139 54.51
14–16 years 98 38.43
≥17 years 8 3.14Abortus 0 195 76.471 44 17.25
>1 16 6.27Parity 0 birth 121 47.451 birth 38 14.90
2–5 birth 87 34.12
>5 birth 9 3.53
Type of uterine fibroid Subserous 39 15.29Intramural 79 30.98Submucosa 18 7.06Multiple 119 46.67Treatment Medication 10 3.92Myomectomy 97 38.04Hysterectomy 148 58.04
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Table 3 Combination of Age, Menarche, Parity on Treatment Option of Uterine Fibroid Based 
  on Reproduction Age 
Combination n
Treatment
Medication Myomectomy HysterectomyA1M1 and, P1 4 0 3 1P2 0 0 0 0P3 0 0 0 0P4 0 0 0 0A1M2 and,P1 38 1 27 10P2 8 1 6 1P3 9 0 2 7P4 0 0 0 0A1M3 and, P1 17 2 11 4P2 5 0 3 2P3 12 0 2 10P4 0 0 0 0A1M4 and,P1 2 0 2 0P2 0 0 0 0P3 0 0 0 0P4 0 0 0 0
Note: A= Age: A1 (15-40 years), A2 (41-46 years), A3 (47-51 years) and A4 (≥52 years), M = Menarche: M1 (< 11 years), 
M2 (11-13 years), M3 (14-16 years) and M4 (≥17 years), P = Parity: P1 (0 birth), P2 (1 birth), P3 (2-5 birth), P4 (>5 
birth)
accordance with a study by Ziemerman et al.3 
that stated the age group 40-49 years has a high 
prevalence of uterine fibroids. Uterine Fibroids occurring in menstruating women, showed the reliance on ovarian steroids, especially estrogen and progesterone that had a role in the development of this disease.10 Another study stated that at the premenopause age, increase urine concentration of estrogen and androgen compared to normal women, could be a predictor in the development of uterine 
fibroids.13Based on the education status, uterine 
fibroids occur most commonly in women who had already graduated from senior high school and college. The level of education was suspected to increase the stress level of a person.8 This was stated by Shen et al.8 that higher level of education was one of the other 
factors on developing uterine fibroids, due to stress level. Stress in a person who had a higher education was related to the changing endocrine system in women via steroid hormone, due to the disturbance of HPA axis responses to stress that result in changes of metabolism steroid hormone, and particularly 
led to the development of uterine fibroids.8,14In this study, normal menarche age had the highest frequency of all groups. This result is in accordance with the study of He et al.15 
in China which stated that ≤14 years old women have a higher percentage of uterine 
fibroids compared to 15–16 and ≥17 years old groups.15 It suspected that there are other 
factors contributing to uterine fibroids, such as smoking, exercise and alcohol consumption. Those factors make women more susceptible 
to develop uterine fibroids.8
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Additionally, nulliparous women had the 
highest frequency of uterine fibroids. Uterine 
fibroids affect fertility due to inflammation of the endometrium, inhibition transport of gamete embryo in the uterus, blood supply and anatomical disorders in the uterine cavity caused by development of the tumor. This condition has a devastating effect on fertility.16,17 Childbearing age women 
preparing for her first pregnancy, and have 
difficulty  getting pregnant should be aware of the possibility of obstetric complication risks 
caused by uterine fibroids.16
Although cases of uterine fibroids in the multiparous group were second rank compared to other groups, this study discovered that this situation existed. This 
finding was in contradictory with the existing theory. Multiparity reduced the risk of uterine 
fibroid.13 After the delivery myometrium will 
return to its normal state, such as weight, 
blood flow, and the size of cells by apoptosis and differentiation through the process of involution reduced blood supply to the myometrium.9 This explanation of uterine 
fibroids in the multiparous group is still unknown. 
Furthermore, multiple uterine fibroids were 
the most type in this study. This finding was not similar to a study conducted in Surakarta which stated that the highest number of uterine 
fibroid is intramural, while the multiple is the least of all.17 This result was also different with a study  conducted by Sarkodie et al.5 in Ghana. There was no clear explanation about the 
differences, whether there was spesific factors in some areas related to the pathogenesis and 
histologically findings.Additionally, the most treatment performed was hysterectomy. This was consistent with a 
Table 4 Combination of Age, Menarche, Parity on Treatment Option of Uterine Fibroid Based 
  on Pre-menopause Age
Combination n
Treatment
Medication Myomectomy HysterectomyA2M1 and, P1 3 1 1 1P2 1 0 1 0P3 0 0 0 0P4 1 0 0 1A2M2 and,P1 27 1 15 11P2 11 0 3 8P3 18 1 1 16P4 1 0 1 0A2M3 and,P1 16 1 7 8P2 7 0 1 6P3 16 0 3 13P4 0 0 0 0A2M4 and, P1 1 0 1 0P2 1 0 0 1P3 1 0 0 1P4 1 0 0 1
Note: A= Age : A1 (15-40 years), A2 (41-46 years), A3 (47-51 years) and A4 (≥52 years), M = Menarche : M1 (< 11 years), 
M2 (11-13 years), M3 (14-16 years) and M4 (≥17 years), P = Parity : P1 (0 birth), P2 (1 birth), P3 (2-5 birth), P4 (>5 
birth)
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previous study in Medan.7 Hysterectomy is the main therapeutic indication of uterine 
fibroids in the United States.18 According to the management of the National Institute for Health 
and Care Excellence (NICE), hysterectomy may be performed if medication treatment failed and women did not want preserved their fertility.16 This study discovered an interesting result, that in some cases, hysterectomy was performed in women who had never delivered. The reason why this operation was perfomed was unclear. In this case, the most combination 
of characteristics uterine fibroids was nulliparous. This disease most occurs in nulliparous women with normal reproductive age and normal menarche, followed by nulliparous women with premenopause and normal menarche. This condition becomes a particular concern to nulliparous women to 
early detect their reproductive system related 
to uterine fibroids.Limitations of this study are the data collection from medical records, which are incomplete since not all patient characteristics 
related to the risk factor for uterine fibroids are recorded, such as anthropometry, family history, medical history, and lifestyles such as smoking, exercise, medicine.The conclusion of this study, nulliparous in women is the most characteristics in uterine 
fibroids, which occurred in reproductive and premenopausal age with normal menarche and myomectomy as treatment.
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